Annual Total Liabilities
$4.45 M
-$19.28 M-81.25%
31 March 2024
Summary:
Portage Biotech annual total liabilities is currently $4.45 million, with the most recent change of -$19.28 million (-81.25%) on 31 March 2024. During the last 3 years, it has fallen by -$22.81 million (-83.67%). PRTG annual total liabilities is now -84.77% below its all-time high of $29.23 million, reached on 31 March 2022.PRTG Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.01 M
-$1.42 M-41.32%
30 September 2024
Summary:
Portage Biotech quarterly total liabilities is currently $2.01 million, with the most recent change of -$1.42 million (-41.32%) on 30 September 2024. Over the past year, it has dropped by -$23.39 million (-92.08%). PRTG quarterly total liabilities is now -95.25% below its all-time high of $42.38 million, reached on 31 December 2022.PRTG Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -81.3% | -92.1% |
3 y3 years | -83.7% | -91.9% |
5 y5 years | -82.3% | -92.0% |
PRTG Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -84.8% | at low | -95.3% | at low |
5 y | 5 years | -84.8% | at low | -95.3% | at low |
alltime | all time | -84.8% | >+9999.0% | -95.3% | >+9999.0% |
Portage Biotech Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $2.01 M(-41.3%) |
June 2024 | - | $3.43 M(-23.0%) |
Mar 2024 | $4.45 M(-81.3%) | $4.45 M(-74.9%) |
Dec 2023 | - | $17.70 M(-30.3%) |
Sept 2023 | - | $25.40 M(-1.2%) |
June 2023 | - | $25.72 M(+8.4%) |
Mar 2023 | $23.73 M(-18.8%) | $23.73 M(-44.0%) |
Dec 2022 | - | $42.38 M(+9.5%) |
Sept 2022 | - | $38.72 M(+39.0%) |
June 2022 | - | $27.86 M(-4.7%) |
Mar 2022 | $29.23 M(+7.2%) | $29.23 M(+20.6%) |
Dec 2021 | - | $24.24 M(-2.5%) |
Sept 2021 | - | $24.86 M(-6.8%) |
June 2021 | - | $26.68 M(-2.1%) |
Mar 2021 | $27.26 M(-1.0%) | $27.26 M(+18.9%) |
Dec 2020 | - | $22.93 M(-13.4%) |
Sept 2020 | - | $26.49 M(-4.2%) |
June 2020 | - | $27.64 M(+0.4%) |
Mar 2020 | $27.53 M(+9.4%) | $27.53 M(+7.6%) |
Dec 2019 | - | $25.59 M(+1.5%) |
Sept 2019 | - | $25.22 M(-1.0%) |
June 2019 | - | $25.46 M(+1.2%) |
Mar 2019 | $25.16 M(+6451.6%) | $25.16 M(+6237.0%) |
Dec 2018 | - | $397.00 K(+35.5%) |
Sept 2018 | - | $293.00 K(-17.9%) |
June 2018 | - | $357.00 K(-7.0%) |
Mar 2018 | $384.00 K(+23.9%) | $384.00 K(-83.8%) |
Dec 2017 | - | $2.38 M(+456.2%) |
Sept 2017 | - | $427.00 K(+14.2%) |
June 2017 | - | $373.80 K(+20.6%) |
Mar 2017 | $310.00 K(+3.4%) | $310.00 K(+136.3%) |
Dec 2016 | - | $131.20 K(+70.8%) |
Sept 2016 | - | $76.80 K(-92.7%) |
June 2016 | - | $1.05 M(+249.6%) |
Mar 2016 | $299.70 K(-51.7%) | $299.70 K(+268.6%) |
Dec 2015 | - | $81.30 K(-53.8%) |
Sept 2015 | - | $175.90 K(-72.0%) |
June 2015 | - | $628.00 K(+1.2%) |
Mar 2015 | $620.60 K(+223.2%) | $620.60 K(-38.9%) |
Dec 2014 | - | $1.02 M(+74.4%) |
Sept 2014 | - | $582.90 K(+17.4%) |
June 2014 | - | $496.40 K(+158.5%) |
Mar 2014 | $192.00 K(-57.0%) | $192.00 K(+103.4%) |
Dec 2013 | - | $94.40 K(-5.3%) |
Sept 2013 | - | $99.70 K(-41.4%) |
June 2013 | - | $170.10 K(-61.9%) |
Mar 2013 | $446.90 K | $446.90 K(+257.2%) |
Dec 2012 | - | $125.10 K(-61.8%) |
Sept 2012 | - | $327.80 K(-74.7%) |
Date | Annual | Quarterly |
---|---|---|
June 2012 | - | $1.30 M(-51.2%) |
Mar 2012 | $2.66 M(+289.8%) | $2.66 M(+162.4%) |
Dec 2011 | - | $1.01 M(+41.8%) |
Sept 2011 | - | $715.40 K(+0.3%) |
June 2011 | - | $713.40 K(+4.5%) |
Mar 2011 | $682.80 K(-80.5%) | $682.80 K(-67.0%) |
Dec 2010 | - | $2.07 M(+13.9%) |
Sept 2010 | - | $1.82 M(+1.8%) |
June 2010 | - | $1.78 M(-49.1%) |
Mar 2010 | $3.51 M(+2811.3%) | $3.51 M(-77.9%) |
Dec 2009 | - | $15.85 M(>+9900.0%) |
Sept 2009 | - | $77.20 K(-54.6%) |
June 2009 | - | $170.10 K(+41.3%) |
Mar 2009 | $120.40 K(+110.1%) | $120.40 K(+38.7%) |
Dec 2008 | - | $86.80 K(+150.1%) |
Sept 2008 | - | $34.70 K(-36.6%) |
June 2008 | - | $54.70 K(-4.5%) |
Mar 2008 | $57.30 K(+36.4%) | $57.30 K(+34.5%) |
Dec 2007 | - | $42.60 K(+7.6%) |
Sept 2007 | - | $39.60 K(-36.9%) |
June 2007 | - | $62.80 K(+49.5%) |
Mar 2007 | $42.00 K(-70.3%) | $42.00 K(+159.3%) |
Dec 2006 | - | $16.20 K(-64.7%) |
Sept 2006 | - | $45.90 K(+10.1%) |
June 2006 | - | $41.70 K(-70.5%) |
Mar 2006 | $141.50 K(+37.6%) | $141.50 K(+52.2%) |
Dec 2005 | - | $93.00 K(+116.3%) |
Sept 2005 | - | $43.00 K(-39.0%) |
June 2005 | - | $70.50 K(-31.4%) |
Mar 2005 | $102.80 K(-84.4%) | $102.80 K(-40.7%) |
Dec 2004 | - | $173.40 K(-26.2%) |
Sept 2004 | - | $235.10 K(+49.7%) |
June 2004 | - | $157.00 K(-76.2%) |
Mar 2004 | $660.60 K(+182.5%) | $660.60 K(+19.9%) |
Dec 2003 | - | $551.10 K(+19.4%) |
Sept 2003 | - | $461.70 K(+71.8%) |
June 2003 | - | $268.80 K(+15.0%) |
Mar 2003 | $233.80 K(+84.8%) | $233.80 K(+11.5%) |
Dec 2002 | - | $209.70 K(+11.8%) |
Sept 2002 | - | $187.60 K(+24.9%) |
June 2002 | - | $150.20 K(+18.7%) |
Mar 2002 | $126.50 K(+33.7%) | $126.50 K(-4.0%) |
Dec 2001 | - | $131.80 K(+81.8%) |
Sept 2001 | - | $72.50 K(-9.7%) |
June 2001 | - | $80.30 K(-15.1%) |
Mar 2001 | $94.60 K(-37.6%) | $94.60 K(-27.3%) |
Dec 2000 | - | $130.10 K |
Mar 2000 | $151.70 K(+133.0%) | - |
Mar 1999 | $65.10 K(-86.9%) | - |
Mar 1998 | $496.70 K | - |
FAQ
- What is Portage Biotech annual total liabilities?
- What is the all time high annual total liabilities for Portage Biotech?
- What is Portage Biotech annual total liabilities year-on-year change?
- What is Portage Biotech quarterly total liabilities?
- What is the all time high quarterly total liabilities for Portage Biotech?
- What is Portage Biotech quarterly total liabilities year-on-year change?
What is Portage Biotech annual total liabilities?
The current annual total liabilities of PRTG is $4.45 M
What is the all time high annual total liabilities for Portage Biotech?
Portage Biotech all-time high annual total liabilities is $29.23 M
What is Portage Biotech annual total liabilities year-on-year change?
Over the past year, PRTG annual total liabilities has changed by -$19.28 M (-81.25%)
What is Portage Biotech quarterly total liabilities?
The current quarterly total liabilities of PRTG is $2.01 M
What is the all time high quarterly total liabilities for Portage Biotech?
Portage Biotech all-time high quarterly total liabilities is $42.38 M
What is Portage Biotech quarterly total liabilities year-on-year change?
Over the past year, PRTG quarterly total liabilities has changed by -$23.39 M (-92.08%)